Sandbox Captopril tablet2

Sandbox Captopril tablet2
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]

For information about , click [[{{{genericName}}}|here]].

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Sandbox Captopril tablet2 is {{{aOrAn}}} {{{drugClass}}} drug that is FDA approved for the treatment of {{{indication}}}. Adverse reactions include {{{adverseReactions}}}.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Condition 1

• Dosing Information

(Dosage)

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

Condition 1

• Developed by: (Organization)

• Class of Recommendation: (Class) (Link)

• Strength of Evidence: (Category A/B/C) (Link)

• Dosing Information/Recommendation

• (Dosage)

Non–Guideline-Supported Use

Condition 1

• Dosing Information

• There is limited information about Off-Label Non–Guideline-Supported Use of Sandbox Captopril tablet2 in adult patients.==Pediatric Indications and Dosage==

FDA-Labeled Indications and Dosage (Pediatric)

Condition 1

• Dosing Information

(Dosage)===Off-Label Use and Dosage (Pediatric)===

Guideline-Supported Use

Condition 1

• Developed by: (Organization)

• Class of Recommendation: (Class) (Link)

• Strength of Evidence: (Category A/B/C) (Link)

• Dosing Information/Recommendation

• (Dosage)====Non–Guideline-Supported Use====

Condition 1

• Dosing Information

• There is limited information about Off-Label Non–Guideline-Supported Use of Sandbox Captopril tablet2 in pediatric patients.

Contraindications

• Condition 1
• Condition 2
• Condition 3
• Condition 4
• Condition 5

Warnings

Conidition 1

(Description)

Adverse Reactions

Clinical Trials Experience

Central Nervous System

(list/description of adverse reactions)

Cardiovascular

(list/description of adverse reactions)

Respiratory

(list/description of adverse reactions)

Gastrointestinal

(list/description of adverse reactions)

Hypersensitive Reactions

(list/description of adverse reactions)

Miscellaneous

(list/description of adverse reactions)

Postmarketing Experience

Central Nervous System

(list/description of adverse reactions)

Cardiovascular

(list/description of adverse reactions)

Respiratory

(list/description of adverse reactions)

Gastrointestinal

(list/description of adverse reactions)

Hypersensitive Reactions

(list/description of adverse reactions)

Miscellaneous

(list/description of adverse reactions)

Drug Interactions

• (Drug 1)

• (Description)

• (Drug 2)

• (Description)

• (Drug 3)

• (Description)

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

There is no FDA guidance on usage of Sandbox Captopril tablet2 in women who are pregnant.

Pregnancy Category (AUS):

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Sandbox Captopril tablet2 in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Sandbox Captopril tablet2 during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Sandbox Captopril tablet2 in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Sandbox Captopril tablet2 in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Sandbox Captopril tablet2 in geriatric settings.

Gender

There is no FDA guidance on the use of Sandbox Captopril tablet2 with respect to specific gender populations.

Race

There is no FDA guidance on the use of Sandbox Captopril tablet2 with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Sandbox Captopril tablet2 in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Sandbox Captopril tablet2 in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Sandbox Captopril tablet2 in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Sandbox Captopril tablet2 in patients who are immunocompromised.